BRCA2 and ovarian neoplasm: Moreover, a recent work showed that EZH2 expression predicts outcome in patients with BRCA2-mutant ovarian tumors by regulating genomic stability at stalled replication forks [42], suggesting a possible connection between EZH2 and BRCA2.